LP
CVS icon

LGL Partners’s CVS Health CVS Stock Holding History

LGL Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-3,600
Closed -$290K – 62
2017
Q2 		$290K Sell
3,600
-379
-10% -$29.9K 0.16% 73
2017
Q1 		$312K Buy
3,979
+220
+6% +$17.6K 0.16% 68
2016
Q4 		$297K Hold
3,759
– – 0.16% 72
2016
Q3 		$327K Hold
3,759
– – 0.17% 69
2016
Q2 		$359K Hold
3,759
– – 0.2% 61
2016
Q1 		$390K Hold
3,759
– – 0.2% 61
2015
Q4 		$367K Buy
+3,759
New +$368K 0.2% 59

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

LGL Partners's CVS Position: Q3 2017 in Review

LGL Partners sold out of CVS Health (CVS) in Q3 2017, closing a stake of 3,600 shares — an estimated $290K sold.

LGL Partners first reported a position in CVS in Q4 2015 and held it in 7 quarters. The position peaked at $390K in Q1 2016. 1,531 funds tracked by Wall St. Rank hold CVS as of Q3 2017.

  • LGL Partners reported no remaining CVS Health position as of Q3 2017 after selling out during the quarter.
  • LGL Partners sold 3,600 CVS Health shares in Q3 2017, an estimated $290K.
  • LGL Partners first reported a position in CVS Health in Q4 2015 and held it in 7 quarters.
  • LGL Partners's CVS Health position peaked at $390K in Q1 2016.
  • 1,531 funds tracked by Wall St. Rank held CVS Health as of Q3 2017.

Based on LGL Partners's 13F filing for Q3 2017, filed 14 Nov 2017.